These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36852665)

  • 1. Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.
    Scarpa F; Sanna D; Azzena I; Casu M; Cossu P; Fiori PL; Benvenuto D; Imperia E; Giovanetti M; Ceccarelli G; Cauda R; Cassone A; Pascarella S; Ciccozzi M
    J Med Virol; 2023 Mar; 95(3):e28625. PubMed ID: 36852665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant.
    Scarpa F; Azzena I; Ciccozzi A; Giovanetti M; Locci C; Casu M; Fiori PL; Borsetti A; Cella E; Quaranta M; Pascarella S; Sanna D; Ciccozzi M
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
    Tamura T; Ito J; Uriu K; Zahradnik J; Kida I; Anraku Y; Nasser H; Shofa M; Oda Y; Lytras S; Nao N; Itakura Y; Deguchi S; Suzuki R; Wang L; Begum MM; Kita S; Yajima H; Sasaki J; Sasaki-Tabata K; Shimizu R; Tsuda M; Kosugi Y; Fujita S; Pan L; Sauter D; Yoshimatsu K; Suzuki S; Asakura H; Nagashima M; Sadamasu K; Yoshimura K; Yamamoto Y; Nagamoto T; Schreiber G; Maenaka K; ; Hashiguchi T; Ikeda T; Fukuhara T; Saito A; Tanaka S; Matsuno K; Takayama K; Sato K
    Nat Commun; 2023 May; 14(1):2800. PubMed ID: 37193706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion.
    Scarpa F; Sanna D; Benvenuto D; Borsetti A; Azzena I; Casu M; Fiori PL; Giovanetti M; Maruotti A; Ceccarelli G; Caruso A; Caccuri F; Cauda R; Cassone A; Pascarella S; Ciccozzi M
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5.
    Scarpa F; Azzena I; Locci C; Casu M; Fiori PL; Ciccozzi A; Angeletti S; Imperia E; Giovanetti M; Maruotti A; Borsetti A; Cauda R; Cassone A; Via A; Pascarella S; Sanna D; Ciccozzi M
    Microorganisms; 2023 Mar; 11(4):. PubMed ID: 37110335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023.
    Arantes I; Gomes M; Ito K; Sarafim S; Gräf T; Miyajima F; Khouri R; de Carvalho FC; de Almeida WAF; Siqueira MM; Resende PC; Naveca FG; Bello G;
    Microbiol Spectr; 2024 Mar; 12(3):e0383123. PubMed ID: 38315011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA.
    Ramaiah A; Khubbar M; Akinyemi K; Bauer A; Carranza F; Weiner J; Bhattacharyya S; Payne D; Balakrishnan N
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
    Xia S; Jiao F; Wang L; Yu X; Lu T; Fu Y; Huang Z; Li X; Huang J; Wang Q; Man Q; Xiong L; Jiang S; Lu L
    J Med Virol; 2023 Mar; 95(3):e28641. PubMed ID: 36890632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A regional genomic surveillance program is implemented to monitor the occurrence and emergence of SARS-CoV-2 variants in Yubei District, China.
    Liu F; Deng P; He J; Chen X; Jiang X; Yan Q; Xu J; Hu S; Yan J
    Virol J; 2024 Jan; 21(1):13. PubMed ID: 38191416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages.
    Scarpa F; Locci C; Azzena I; Casu M; Fiori PL; Ciccozzi A; Giovanetti M; Quaranta M; Ceccarelli G; Pascarella S; Ciccozzi M; Sanna D
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023.
    Ma KC; Shirk P; Lambrou AS; Hassell N; Zheng XY; Payne AB; Ali AR; Batra D; Caravas J; Chau R; Cook PW; Howard D; Kovacs NA; Lacek KA; Lee JS; MacCannell DR; Malapati L; Mathew S; Mittal N; Nagilla RR; Parikh R; Paul P; Rambo-Martin BL; Shepard SS; Sheth M; Wentworth DE; Winn A; Hall AJ; Silk BJ; Thornburg N; Kondor R; Scobie HM; Paden CR
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(24):651-656. PubMed ID: 37319011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022-August 2023.
    Puenpa J; Chansaenroj J; Suwannakarn K; Poovorawan Y
    Sci Rep; 2024 Jan; 14(1):645. PubMed ID: 38182705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
    La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
    Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
    Parums DV
    Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pan-sarbecovirus vaccine based on RBD of SARS-CoV-2 original strain elicits potent neutralizing antibodies against XBB in non-human primates.
    Liu Z; Zhou J; Wang X; Xu W; Teng Z; Chen H; Chen M; Zhang G; Wang Y; Huang J; Wang Q; Jiang S; Lu L
    Proc Natl Acad Sci U S A; 2023 Mar; 120(11):e2221713120. PubMed ID: 36897979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.
    He C; Alu A; Lei H; Yang J; Hong W; Song X; Li J; Yang L; Wang W; Shen G; Lu G; Wei X
    MedComm (2020); 2023 Jun; 4(3):e263. PubMed ID: 37125241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
    Link-Gelles R; Ciesla AA; Roper LE; Scobie HM; Ali AR; Miller JD; Wiegand RE; Accorsi EK; Verani JR; Shang N; Derado G; Britton A; Smith ZR; Fleming-Dutra KE
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):119-124. PubMed ID: 36730051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected With Omicron Subvariants and the XBB Recombinant Variant.
    Karyakarte RP; Das R; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Rajmane MV; Kulkarni PP; Nizarudeen S; Joshi S; Potdar V; Karmodiya K
    Cureus; 2023 Feb; 15(2):e35261. PubMed ID: 36968876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages.
    Kumar N; Kaushik R; Singh A; Uversky VN; Zhang KYJ; Sahu U; Bhatia S; Sanyal A
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron Sub-Lineage BA.5 and Recombinant XBB Evasion from Antibody Neutralisation in BNT162b2 Vaccine Recipients.
    Brandolini M; Gatti G; Grumiro L; Zannoli S; Arfilli V; Cricca M; Dirani G; Denicolò A; Marino MM; Manera M; Mancini A; Taddei F; Semprini S; Sambri V
    Microorganisms; 2023 Jan; 11(1):. PubMed ID: 36677483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.